Bottom line
FLCE vs AVEM: the short answer
FLCE (Frontier Asset U.S. Large Cap Equity ETF) and AVEM (Avantis Emerging Markets Equity ETF) are both etfs.
But AVEM is far broader, holding 3,921 positions to 7 for FLCE, so beyond the top names it adds exposure FLCE doesn't have.
AVEM is cheaper at 0.33% vs 0.86% — a difference of $53 a year per $10,000 invested.
Over one year, FLCE returned +14.2% vs +7.5% for AVEM (reporting dates differ).
Updated Nov 19, 2026
FLCE vs AVEM side by side
| FLCE | AVEM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SEI | American Century |
| Category | Emerging Markets | Emerging Markets |
| Expense ratio | 0.86% | 0.33% |
| Annual cost per $10k | $86 | $33 |
| 10-yr cost on $10k (prospectus) | $1,061 | $419 |
| Max front load | None | None |
| 12b-1 fee | — | — |
| 1-yr return | +14.2% | +7.5% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | — |
| Best quarter | +8.5% | +21.7% |
| Worst quarter | −3.5% | −27.7% |
| Net assets (fund) | $80.3M | $26.0B |
| Number of holdings | 7 | 3,921 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FLCE and AVEM share none of their top holdings.
FLCE top 10
- T Rowe Price US Equity Research ETF — 25.92%
- iShares US Equity Factor ETF — 19.02%
- JPMorgan Active Value ETF — 15.74%
- Vanguard Dividend Appreciation Index Fund — 12.01%
- T Rowe Price Capital Appreciation Equity ETF — 11.26%
- JPMorgan Active Growth ETF — 10.66%
- GMO US Quality ETF — 5.17%
AVEM top 10
- SK hynix Inc — 7.83%
- Taiwan Semiconductor Manufacturing Co Ltd — 6.33%
- Samsung Electronics Co Ltd — 5.70%
- Taiwan Semiconductor Manufacturing Co Ltd — 4.11%
- Tencent Holdings Ltd — 1.51%
- MediaTek Inc — 1.11%
- China Construction Bank Corp — 0.88%
- Alibaba Group Holding Ltd — 0.81%
- Chroma ATE Inc — 0.81%
- Delta Electronics Inc — 0.77%
FAQ
What is the difference between FLCE and AVEM?
Which is cheaper, FLCE or AVEM?
Should I own both FLCE and AVEM?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.